[1]
DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology. The American journal of gastroenterology. 1999 Jun:94(6):1434-42
[PubMed PMID: 10364004]
[2]
Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, Globale Konsensusgruppe. [The Montreal definition and classification of gastroesophageal reflux disease: a global, evidence-based consensus paper]. Zeitschrift fur Gastroenterologie. 2007 Nov:45(11):1125-40
[PubMed PMID: 18027314]
Level 3 (low-level) evidence
[3]
Sonnenberg A, El-Serag HB. Clinical epidemiology and natural history of gastroesophageal reflux disease. The Yale journal of biology and medicine. 1999 Mar-Jun:72(2-3):81-92
[PubMed PMID: 10780569]
[4]
Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005 May:54(5):710-7
[PubMed PMID: 15831922]
Level 1 (high-level) evidence
[5]
Weijenborg PW, Cremonini F, Smout AJ, Bredenoord AJ. PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis. Neurogastroenterology and motility. 2012 Aug:24(8):747-57, e350. doi: 10.1111/j.1365-2982.2012.01888.x. Epub 2012 Feb 6
[PubMed PMID: 22309489]
Level 1 (high-level) evidence
[6]
Thrift AP, Kramer JR, Qureshi Z, Richardson PA, El-Serag HB. Age at onset of GERD symptoms predicts risk of Barrett's esophagus. The American journal of gastroenterology. 2013 Jun:108(6):915-22. doi: 10.1038/ajg.2013.72. Epub 2013 Apr 9
[PubMed PMID: 23567358]
[7]
Ghisa M, Marinelli C, Savarino V, Savarino E. Idiopathic pulmonary fibrosis and GERD: links and risks. Therapeutics and clinical risk management. 2019:15():1081-1093. doi: 10.2147/TCRM.S184291. Epub 2019 Sep 5
[PubMed PMID: 31564886]
[8]
Boeckxstaens GE. The lower oesophageal sphincter. Neurogastroenterology and motility. 2005 Jun:17 Suppl 1():13-21
[PubMed PMID: 15836451]
[9]
Boeckxstaens GE. Alterations confined to the gastro-oesophageal junction: the relationship between low LOSP, TLOSRs, hiatus hernia and acid pocket. Best practice & research. Clinical gastroenterology. 2010 Dec:24(6):821-9. doi: 10.1016/j.bpg.2010.08.011. Epub
[PubMed PMID: 21126696]
[10]
E Souza MÂ, Nobre RA, Bezerra PC, Dos Santos AA, Sifrim D. Anatomical and functional deficiencies of the crural diaphragm in patients with esophagitis. Neurogastroenterology and motility. 2017 Jan:29(1):. doi: 10.1111/nmo.12899. Epub 2016 Jul 14
[PubMed PMID: 27418308]
[11]
Fouad YM, Katz PO, Hatlebakk JG, Castell DO. Ineffective esophageal motility: the most common motility abnormality in patients with GERD-associated respiratory symptoms. The American journal of gastroenterology. 1999 Jun:94(6):1464-7
[PubMed PMID: 10364008]
[12]
Gutschow CA, Leers JM, Schröder W, Prenzel KL, Fuchs H, Bollschweiler E, Bludau M, Hölscher AH. Effect of aging on esophageal motility in patients with and without GERD. German medical science : GMS e-journal. 2011:9():Doc22. doi: 10.3205/000145. Epub 2011 Aug 18
[PubMed PMID: 21863136]
[13]
Boeckxstaens GE, Rohof WO. Pathophysiology of gastroesophageal reflux disease. Gastroenterology clinics of North America. 2014 Mar:43(1):15-25. doi: 10.1016/j.gtc.2013.11.001. Epub 2013 Dec 27
[PubMed PMID: 24503356]
[14]
Beaumont H, Bennink RJ, de Jong J, Boeckxstaens GE. The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GORD. Gut. 2010 Apr:59(4):441-51. doi: 10.1136/gut.2009.178061. Epub 2009 Aug 2
[PubMed PMID: 19651625]
[15]
Rubenstein JH, Chen JW. Epidemiology of gastroesophageal reflux disease. Gastroenterology clinics of North America. 2014 Mar:43(1):1-14. doi: 10.1016/j.gtc.2013.11.006. Epub 2013 Dec 27
[PubMed PMID: 24503355]
[16]
Emerenziani S, Rescio MP, Guarino MP, Cicala M. Gastro-esophageal reflux disease and obesity, where is the link? World journal of gastroenterology. 2013 Oct 21:19(39):6536-9. doi: 10.3748/wjg.v19.i39.6536. Epub
[PubMed PMID: 24151378]
[17]
Asanuma K, Iijima K, Shimosegawa T. Gender difference in gastro-esophageal reflux diseases. World journal of gastroenterology. 2016 Feb 7:22(5):1800-10. doi: 10.3748/wjg.v22.i5.1800. Epub
[PubMed PMID: 26855539]
[18]
Chang P, Friedenberg F. Obesity and GERD. Gastroenterology clinics of North America. 2014 Mar:43(1):161-73. doi: 10.1016/j.gtc.2013.11.009. Epub 2013 Dec 27
[PubMed PMID: 24503366]
[19]
Yang HJ, Chang Y, Park SK, Jung YS, Park JH, Park DI, Cho YK, Ryu S, Sohn CI. Nonalcoholic Fatty Liver Disease Is Associated with Increased Risk of Reflux Esophagitis. Digestive diseases and sciences. 2017 Dec:62(12):3605-3613. doi: 10.1007/s10620-017-4805-6. Epub 2017 Oct 23
[PubMed PMID: 29063416]
[20]
Ness-Jensen E, Lagergren J. Tobacco smoking, alcohol consumption and gastro-oesophageal reflux disease. Best practice & research. Clinical gastroenterology. 2017 Oct:31(5):501-508. doi: 10.1016/j.bpg.2017.09.004. Epub 2017 Sep 7
[PubMed PMID: 29195669]
[21]
Song EM, Jung HK, Jung JM. The association between reflux esophagitis and psychosocial stress. Digestive diseases and sciences. 2013 Feb:58(2):471-7. doi: 10.1007/s10620-012-2377-z. Epub 2012 Sep 22
[PubMed PMID: 23001402]
[22]
Savarino E, Marabotto E, Bodini G, Pellegatta G, Coppo C, Giambruno E, Brunacci M, Zentilin P, Savarino V. Epidemiology and natural history of gastroesophageal reflux disease. Minerva gastroenterologica e dietologica. 2017 Sep:63(3):175-183. doi: 10.23736/S1121-421X.17.02383-2. Epub 2017 Feb 17
[PubMed PMID: 28215067]
[23]
Nebel OT, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux: incidence and precipitating factors. The American journal of digestive diseases. 1976 Nov:21(11):953-6
[PubMed PMID: 984016]
[24]
Loffeld RJ, van der Putten AB. Rising incidence of reflux oesophagitis in patients undergoing upper gastrointestinal endoscopy. Digestion. 2003:68(2-3):141-4
[PubMed PMID: 14646335]
[25]
Kotzan J, Wade W, Yu HH. Assessing NSAID prescription use as a predisposing factor for gastroesophageal reflux disease in a Medicaid population. Pharmaceutical research. 2001 Sep:18(9):1367-72
[PubMed PMID: 11683254]
[26]
Nelson SP, Kothari S, Wu EQ, Beaulieu N, McHale JM, Dabbous OH. Pediatric gastroesophageal reflux disease and acid-related conditions: trends in incidence of diagnosis and acid suppression therapy. Journal of medical economics. 2009:12(4):348-55. doi: 10.3111/13696990903378680. Epub
[PubMed PMID: 19827992]
[27]
Eichenwald EC, COMMITTEE ON FETUS AND NEWBORN. Diagnosis and Management of Gastroesophageal Reflux in Preterm Infants. Pediatrics. 2018 Jul:142(1):. pii: e20181061. doi: 10.1542/peds.2018-1061. Epub 2018 Jun 18
[PubMed PMID: 29915158]
[29]
Stein DJ, El-Serag HB, Kuczynski J, Kramer JR, Sampliner RE. The association of body mass index with Barrett's oesophagus. Alimentary pharmacology & therapeutics. 2005 Nov 15:22(10):1005-10
[PubMed PMID: 16268976]
[30]
Herregods TV, Bredenoord AJ, Smout AJ. Pathophysiology of gastroesophageal reflux disease: new understanding in a new era. Neurogastroenterology and motility. 2015 Sep:27(9):1202-13. doi: 10.1111/nmo.12611. Epub 2015 Jun 5
[PubMed PMID: 26053301]
Level 3 (low-level) evidence
[31]
Boeckxstaens GE. Review article: the pathophysiology of gastro-oesophageal reflux disease. Alimentary pharmacology & therapeutics. 2007 Jul 15:26(2):149-60
[PubMed PMID: 17593062]
[32]
Castell DO, Murray JA, Tutuian R, Orlando RC, Arnold R. Review article: the pathophysiology of gastro-oesophageal reflux disease - oesophageal manifestations. Alimentary pharmacology & therapeutics. 2004 Dec:20 Suppl 9():14-25
[PubMed PMID: 15527461]
[33]
Usai Satta P, Oppia F, Cabras F. Overview of pathophysiological features of GERD. Minerva gastroenterologica e dietologica. 2017 Sep:63(3):184-197. doi: 10.23736/S1121-421X.17.02390-X. Epub 2017 Mar 1
[PubMed PMID: 28251844]
Level 3 (low-level) evidence
[34]
Niigaki M, Adachi K, Hirakawa K, Furuta K, Kinoshita Y. Association between metabolic syndrome and prevalence of gastroesophageal reflux disease in a health screening facility in Japan. Journal of gastroenterology. 2013 Apr:48(4):463-72. doi: 10.1007/s00535-012-0671-3. Epub 2012 Sep 14
[PubMed PMID: 22976934]
[35]
Corley DA, Kubo A, Levin TR, Block G, Habel L, Zhao W, Leighton P, Quesenberry C, Rumore GJ, Buffler PA. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology. 2007 Jul:133(1):34-41; quiz 311
[PubMed PMID: 17631128]
[36]
Souza RF. Reflux esophagitis and its role in the pathogenesis of Barrett's metaplasia. Journal of gastroenterology. 2017 Jul:52(7):767-776. doi: 10.1007/s00535-017-1342-1. Epub 2017 Apr 27
[PubMed PMID: 28451845]
[37]
Souza RF, Bayeh L, Spechler SJ, Tambar UK, Bruick RK. A new paradigm for GERD pathogenesis. Not acid injury, but cytokine-mediated inflammation driven by HIF-2α: a potential role for targeting HIF-2α to prevent and treat reflux esophagitis. Current opinion in pharmacology. 2017 Dec:37():93-99. doi: 10.1016/j.coph.2017.10.004. Epub 2017 Nov 5
[PubMed PMID: 29112883]
Level 3 (low-level) evidence
[38]
Dunbar KB, Agoston AT, Odze RD, Huo X, Pham TH, Cipher DJ, Castell DO, Genta RM, Souza RF, Spechler SJ. Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes. JAMA. 2016 May 17:315(19):2104-12. doi: 10.1001/jama.2016.5657. Epub
[PubMed PMID: 27187303]
[39]
Takubo K, Honma N, Aryal G, Sawabe M, Arai T, Tanaka Y, Mafune K, Iwakiri K. Is there a set of histologic changes that are invariably reflux associated? Archives of pathology & laboratory medicine. 2005 Feb:129(2):159-63
[PubMed PMID: 15679411]
[40]
Genta RM, Spechler SJ, Kielhorn AF. The Los Angeles and Savary-Miller systems for grading esophagitis: utilization and correlation with histology. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus. 2011 Jan:24(1):10-7. doi: 10.1111/j.1442-2050.2010.01092.x. Epub
[PubMed PMID: 20659145]
[41]
Straumann A, Katzka DA. Diagnosis and Treatment of Eosinophilic Esophagitis. Gastroenterology. 2018 Jan:154(2):346-359. doi: 10.1053/j.gastro.2017.05.066. Epub 2017 Jul 27
[PubMed PMID: 28756235]
[42]
Chu CL, Zhen YB, Lv GP, Li CQ, Li Z, Qi QQ, Gu XM, Yu T, Zhang TG, Zhou CJ, Rui-Ji, Li YQ. Microalterations of esophagus in patients with non-erosive reflux disease: in-vivo diagnosis by confocal laser endomicroscopy and its relationship with gastroesophageal reflux. The American journal of gastroenterology. 2012 Jun:107(6):864-74. doi: 10.1038/ajg.2012.44. Epub 2012 Mar 13
[PubMed PMID: 22415199]
Level 2 (mid-level) evidence
[43]
Nagahara A, Hojo M, Asaoka D, Sasaki H, Oguro M, Mori H, Matsumoto K, Osada T, Yoshizawa T, Watanabe S. Clinical feature of asymptomatic reflux esophagitis in patients who underwent upper gastrointestinal endoscopy. Journal of gastroenterology and hepatology. 2012 Apr:27 Suppl 3():53-7. doi: 10.1111/j.1440-1746.2012.07073.x. Epub
[PubMed PMID: 22486872]
[44]
Kellerman R, Kintanar T. Gastroesophageal Reflux Disease. Primary care. 2017 Dec:44(4):561-573. doi: 10.1016/j.pop.2017.07.001. Epub 2017 Oct 5
[PubMed PMID: 29132520]
[45]
Helm JF, Dodds WJ, Hogan WJ. Salivary response to esophageal acid in normal subjects and patients with reflux esophagitis. Gastroenterology. 1987 Dec:93(6):1393-7
[PubMed PMID: 3678754]
[46]
Naik RD, Vaezi MF. Extra-esophageal gastroesophageal reflux disease and asthma: understanding this interplay. Expert review of gastroenterology & hepatology. 2015 Jul:9(7):969-82. doi: 10.1586/17474124.2015.1042861. Epub 2015 Jun 11
[PubMed PMID: 26067887]
Level 3 (low-level) evidence
[47]
Garza JM, Kaul A. Gastroesophageal reflux, eosinophilic esophagitis, and foreign body. Pediatric clinics of North America. 2010 Dec:57(6):1331-45. doi: 10.1016/j.pcl.2010.09.008. Epub
[PubMed PMID: 21111120]
[48]
Kahrilas PJ, Altman KW, Chang AB, Field SK, Harding SM, Lane AP, Lim K, McGarvey L, Smith J, Irwin RS, CHEST Expert Cough Panel. Chronic Cough Due to Gastroesophageal Reflux in Adults: CHEST Guideline and Expert Panel Report. Chest. 2016 Dec:150(6):1341-1360. doi: 10.1016/j.chest.2016.08.1458. Epub 2016 Sep 7
[PubMed PMID: 27614002]
[49]
Parsons JP, Mastronarde JG. Gastroesophageal reflux disease and asthma. Current opinion in pulmonary medicine. 2010 Jan:16(1):60-3. doi: 10.1097/MCP.0b013e328332ca2f. Epub
[PubMed PMID: 19887939]
Level 3 (low-level) evidence
[50]
Marsicano JA, de Moura-Grec PG, Bonato RC, Sales-Peres Mde C, Sales-Peres A, Sales-Peres SH. Gastroesophageal reflux, dental erosion, and halitosis in epidemiological surveys: a systematic review. European journal of gastroenterology & hepatology. 2013 Feb:25(2):135-41. doi: 10.1097/MEG.0b013e32835ae8f7. Epub
[PubMed PMID: 23111415]
Level 2 (mid-level) evidence
[51]
Badillo R, Francis D. Diagnosis and treatment of gastroesophageal reflux disease. World journal of gastrointestinal pharmacology and therapeutics. 2014 Aug 6:5(3):105-12. doi: 10.4292/wjgpt.v5.i3.105. Epub
[PubMed PMID: 25133039]
[52]
Mattox HE 3rd, Richter JE. Prolonged ambulatory esophageal pH monitoring in the evaluation of gastroesophageal reflux disease. The American journal of medicine. 1990 Sep:89(3):345-56
[PubMed PMID: 2203264]
[53]
Dent J. Endoscopic grading of reflux oesophagitis: the past, present and future. Best practice & research. Clinical gastroenterology. 2008:22(4):585-99. doi: 10.1016/j.bpg.2008.01.002. Epub
[PubMed PMID: 18656818]
[54]
Hemmink GJ, Bredenoord AJ, Weusten BL, Monkelbaan JF, Timmer R, Smout AJ. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor? The American journal of gastroenterology. 2008 Oct:103(10):2446-53. doi: 10.1111/j.1572-0241.2008.02033.x. Epub 2008 Aug 5
[PubMed PMID: 18684197]
[55]
Saleh CM, Smout AJ, Bredenoord AJ. The diagnosis of gastro-esophageal reflux disease cannot be made with barium esophagograms. Neurogastroenterology and motility. 2015 Feb:27(2):195-200. doi: 10.1111/nmo.12457. Epub 2014 Oct 19
[PubMed PMID: 25327284]
[56]
Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, Johnson F, Hongo M, Richter JE, Spechler SJ, Tytgat GN, Wallin L. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999 Aug:45(2):172-80
[PubMed PMID: 10403727]
Level 1 (high-level) evidence
[57]
Pace F, Pace M. The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease. Expert review of gastroenterology & hepatology. 2010 Aug:4(4):423-7. doi: 10.1586/egh.10.38. Epub
[PubMed PMID: 20678016]
[58]
Gyawali CP, Fass R. Management of Gastroesophageal Reflux Disease. Gastroenterology. 2018 Jan:154(2):302-318. doi: 10.1053/j.gastro.2017.07.049. Epub 2017 Aug 5
[PubMed PMID: 28827081]
[59]
Heidelbaugh JJ, Nostrant TT, Kim C, Van Harrison R. Management of gastroesophageal reflux disease. American family physician. 2003 Oct 1:68(7):1311-8
[PubMed PMID: 14567485]
[60]
Kaltenbach T, Crockett S, Gerson LB. Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Archives of internal medicine. 2006 May 8:166(9):965-71
[PubMed PMID: 16682569]
[61]
Surdea-Blaga T, Negrutiu DE, Palage M, Dumitrascu DL. Food and Gastroesophageal Reflux Disease. Current medicinal chemistry. 2019:26(19):3497-3511. doi: 10.2174/0929867324666170515123807. Epub
[PubMed PMID: 28521699]
[62]
Umezawa M, Kawami N, Hoshino S, Hoshikawa Y, Koizumi E, Takenouchi N, Hanada Y, Kaise M, Iwakiri K. Efficacy of On-Demand Therapy Using 20-mg Vonoprazan for Mild Reflux Esophagitis. Digestion. 2018:97(4):309-315. doi: 10.1159/000485795. Epub 2018 Mar 7
[PubMed PMID: 29514137]
[63]
Spechler SJ. Eosinophilic esophagitis: novel concepts regarding pathogenesis and clinical manifestations. Journal of gastroenterology. 2019 Oct:54(10):837-844. doi: 10.1007/s00535-019-01604-7. Epub 2019 Jul 24
[PubMed PMID: 31342146]
[64]
Zhang HY, Spechler SJ, Souza RF. Esophageal adenocarcinoma arising in Barrett esophagus. Cancer letters. 2009 Mar 18:275(2):170-7. doi: 10.1016/j.canlet.2008.07.006. Epub 2008 Aug 13
[PubMed PMID: 18703277]
Level 3 (low-level) evidence
[65]
DeMeester SR. Barrett's oesophagus: treatment with surgery. Best practice & research. Clinical gastroenterology. 2015 Feb:29(1):211-7. doi: 10.1016/j.bpg.2014.12.004. Epub 2014 Dec 18
[PubMed PMID: 25743467]
[66]
Parasa S, Sharma P. Complications of gastro-oesophageal reflux disease. Best practice & research. Clinical gastroenterology. 2013 Jun:27(3):433-42. doi: 10.1016/j.bpg.2013.07.002. Epub
[PubMed PMID: 23998980]
[67]
Ribolsi M, Giordano A, Guarino MPL, Tullio A, Cicala M. New classifications of gastroesophageal reflux disease: an improvement for patient management? Expert review of gastroenterology & hepatology. 2019 Aug:13(8):761-769. doi: 10.1080/17474124.2019.1645596. Epub 2019 Jul 25
[PubMed PMID: 31327288]
[68]
Hopper AD. Improving the diagnosis and management of GORD in adults. The Practitioner. 2015 Apr:259(1781):27-32, 3
[PubMed PMID: 26529827]